Portfolio company
ViewMind
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
ViewMind develops eye-tracking cognitive assessment tools for pharmaceutical researchers and healthcare providers to detect and monitor neurodegenerative diseases and brain health.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Neurotrack
Neurotrack develops digital cognitive assessment tools and health programmes for healthcare providers and pharmaceutical companies to detect and manage Alzheimer's disease.
NeuraLight
The company develops an artificial intelligence platform measuring eye movements to create digital biomarkers for pharmaceutical companies and researchers treating neurological disorders.
neuroClues
This company develops portable eye-tracking medical devices and AI software for clinicians to identify neurological disorders through ocular biomarkers.
Neurovision
This company provides diagnostic blood tests and retinal imaging software to help healthcare providers detect and monitor neurodegenerative diseases.
Cognoptix
This company develops a non-invasive eye scanning system to detect Alzheimer's disease for clinicians and pharmaceutical partners.
Neurowyzr
This company develops digital neuroscience assessment tools to screen for early brain decline in healthcare patients and corporate employees.
MindAhead
This company develops a digital therapy application for individuals with mild cognitive impairment and dementia to slow cognitive decline.
RetiSpec
This company develops artificial intelligence software for retinal imaging to help clinicians detect biomarkers of Alzheimer's disease and other neurodegenerative conditions.
